• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清中循环微RNA的稳定性

Stability of circulating microRNAs in serum.

作者信息

Kupec Tomas, Bleilevens Andreas, Iborra Séverine, Najjari Laila, Wittenborn Julia, Maurer Jochen, Stickeler Elmar

机构信息

Clinic for Gynaecology and Obstetrics, University Hospital RWTH Aachen, Aachen, Germany.

出版信息

PLoS One. 2022 Aug 31;17(8):e0268958. doi: 10.1371/journal.pone.0268958. eCollection 2022.

DOI:10.1371/journal.pone.0268958
PMID:36044434
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9432728/
Abstract

There is a strong body of evidence by several translational studies which demonstrate the potential of circulating miRNAs as a potential biomarker in oncology. However, recent reports documented varying stability of these small RNA molecules in serum samples. The aim of our pilot study was to evaluate the stability of miRNAs in serum in relation to food intake and sample storage. Serum miRNA expression levels of 16 different miRNAs from 8 healthy volunteers were quantified by real-time PCR. 4 samples from each donor were analysed-2 samples (fasting, in the morning and after food intake, at noon) were analysed within 24h and 2 samples (fasting and after food intake, at noon) were stored at -80°C for 14 days and subsequently analysed. Student´s t-test was used to determine significant differences. The detectability of the distinct miRNA as a surrogate for the stability of these small RNA molecules was slightly altered by the storage conditions, but only a miRNA 22-3p, out of the analysed 16 miRNAs, shows significant lower dCq expression (3.821 vs. 4.530; p<0,01) by qPCR dependent on storage conditions (-80°C vs. 4°C). However, miRNA levels were not affected by food intake. The difference between samples taken in the morning (fasting) and at noon (after a normal meal) did not show any significant differences. MiRNAs can be considered to be a relatively stable tool in laboratory diagnostics, but clearly every new assay needs thorough evaluation. The stability of miRNAs documented here in healthy volunteers shows their potential in the search for innovative biomarkers in oncology.

摘要

多项转化研究有大量证据表明,循环微小RNA(miRNA)有潜力成为肿瘤学中的生物标志物。然而,最近的报告记录了这些小RNA分子在血清样本中的稳定性存在差异。我们的初步研究旨在评估血清中miRNA相对于食物摄入和样本储存的稳定性。通过实时聚合酶链反应(PCR)对8名健康志愿者的16种不同miRNA的血清表达水平进行了定量分析。对每个捐赠者的4个样本进行了分析——2个样本(早晨空腹和中午进食后)在24小时内进行分析,另外2个样本(空腹和中午进食后)在-80°C下储存14天,随后进行分析。采用学生t检验来确定显著差异。作为这些小RNA分子稳定性替代指标的不同miRNA的可检测性受储存条件的影响略有改变,但在分析的16种miRNA中,只有miRNA 22 - 3p在依赖于储存条件(-80°C与4°C)的定量PCR中显示出显著更低的dCq表达(3.821对4.530;p<0.01)。然而,miRNA水平不受食物摄入的影响。早晨(空腹)和中午(正常进食后)采集的样本之间的差异未显示出任何显著差异。在实验室诊断中,miRNA可被认为是一种相对稳定的数据,但显然每个新的检测方法都需要进行全面评估。健康志愿者中记录的miRNA稳定性显示了它们在寻找肿瘤学创新生物标志物方面的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fa6/9432728/455598c658af/pone.0268958.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fa6/9432728/d85670394bcb/pone.0268958.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fa6/9432728/e6539af6f3a3/pone.0268958.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fa6/9432728/3cb93d609bea/pone.0268958.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fa6/9432728/3d7b8c3b7f61/pone.0268958.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fa6/9432728/455598c658af/pone.0268958.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fa6/9432728/d85670394bcb/pone.0268958.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fa6/9432728/e6539af6f3a3/pone.0268958.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fa6/9432728/3cb93d609bea/pone.0268958.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fa6/9432728/3d7b8c3b7f61/pone.0268958.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fa6/9432728/455598c658af/pone.0268958.g005.jpg

相似文献

1
Stability of circulating microRNAs in serum.血清中循环微RNA的稳定性
PLoS One. 2022 Aug 31;17(8):e0268958. doi: 10.1371/journal.pone.0268958. eCollection 2022.
2
MicroRNA Isolation by Trizol-Based Method and Its Stability in Stored Serum and cDNA Derivatives.基于Trizol法的微小RNA分离及其在储存血清和cDNA衍生物中的稳定性
Asian Pac J Cancer Prev. 2019 Jun 1;20(6):1641-1647. doi: 10.31557/APJCP.2019.20.6.1641.
3
Serum outperforms plasma in small extracellular vesicle microRNA biomarker studies of adenocarcinoma of the esophagus.血清在食管腺癌的小细胞外囊泡 microRNA 生物标志物研究中优于血浆。
World J Gastroenterol. 2020 May 28;26(20):2570-2583. doi: 10.3748/wjg.v26.i20.2570.
4
Study of the preanalytical variables affecting the measurement of clinically relevant free-circulating microRNAs: focus on sample matrix, platelet depletion, and storage conditions.研究影响临床相关游离 microRNAs 测量的分析前变量:重点关注样本基质、血小板去除和储存条件。
Biochem Med (Zagreb). 2020 Feb 15;30(1):010703. doi: 10.11613/BM.2020.010703. Epub 2019 Dec 15.
5
Challenges and standardization of microRNA profiling in serum and cerebrospinal fluid in dogs suffering from non-infectious inflammatory CNS disease.犬非传染性炎症性中枢神经系统疾病患者血清和脑脊液中 microRNA 谱分析的挑战与标准化。
Acta Vet Scand. 2019 Dec 3;61(1):57. doi: 10.1186/s13028-019-0492-y.
6
MiRNA profiles in blood plasma from mother-child duos in human biobanks and the implication of sample quality: Circulating miRNAs as potential early markers of child health.母婴血液生物样本库中 miRNA 图谱及样本质量的影响:循环 miRNA 作为儿童健康的潜在早期标志物。
PLoS One. 2020 Apr 2;15(4):e0231040. doi: 10.1371/journal.pone.0231040. eCollection 2020.
7
Sources to variability in circulating human miRNA signatures.循环 miRNA 特征变异性的来源。
RNA Biol. 2017 Dec 2;14(12):1791-1798. doi: 10.1080/15476286.2017.1367888. Epub 2017 Sep 13.
8
The Diagnostic Value of Serum miRNA-221-3p, miRNA-382-5p, and miRNA-4271 in Ischemic Stroke.血清miRNA-221-3p、miRNA-382-5p和miRNA-4271在缺血性卒中中的诊断价值
J Stroke Cerebrovasc Dis. 2017 May;26(5):1055-1060. doi: 10.1016/j.jstrokecerebrovasdis.2016.12.019. Epub 2017 Jan 19.
9
Evaluation of fecal microRNA stability in healthy cats.健康猫粪便中微小RNA稳定性的评估
Vet Clin Pathol. 2019 Sep;48(3):455-460. doi: 10.1111/vcp.12757. Epub 2019 Jun 26.
10
Circulating microRNAs as emerging cardiac biomarkers responsive to acute exercise.循环 microRNAs 作为新兴的心脏生物标志物,对急性运动有反应。
Int J Cardiol. 2018 Aug 1;264:130-136. doi: 10.1016/j.ijcard.2018.02.092.

引用本文的文献

1
miRNA-mediated resistance mechanisms in prostate cancer: implications for targeted therapy and metastatic progression.前列腺癌中微小RNA介导的耐药机制:对靶向治疗和转移进展的影响
Med Oncol. 2025 Aug 29;42(10):454. doi: 10.1007/s12032-025-03006-7.
2
MicroRNAs as Potential Biomarkers for Alzheimer's Disease in Women.微小RNA作为女性阿尔茨海默病的潜在生物标志物
Genes (Basel). 2025 Aug 11;16(8):943. doi: 10.3390/genes16080943.
3
Strength training and sarcopenia-a mandatory link: focus on MicroRNAs.力量训练与肌肉减少症——必然联系:聚焦于微小RNA

本文引用的文献

1
Down-Regulation of miR-194-5p for Predicting Metastasis in Breast Cancer Cells.下调 miR-194-5p 预测乳腺癌细胞转移。
Int J Mol Sci. 2021 Dec 28;23(1):325. doi: 10.3390/ijms23010325.
2
Let-7a-5p, miR-100-5p, miR-101-3p, and miR-199a-3p Hyperexpression as Potential Predictive Biomarkers in Early Breast Cancer Patients.Let-7a-5p、miR-100-5p、miR-101-3p和miR-199a-3p高表达作为早期乳腺癌患者潜在的预测生物标志物
J Pers Med. 2021 Aug 20;11(8):816. doi: 10.3390/jpm11080816.
3
Circulating miR-99a-5p Expression in Plasma: A Potential Biomarker for Early Diagnosis of Breast Cancer.
Front Aging. 2025 Jul 30;6:1554340. doi: 10.3389/fragi.2025.1554340. eCollection 2025.
4
Diagnostic Potential of Serum Circulating miRNAs for Endometriosis in Patients with Chronic Pelvic Pain.血清循环微小RNA对慢性盆腔疼痛患者子宫内膜异位症的诊断潜力
J Clin Med. 2025 Jul 21;14(14):5154. doi: 10.3390/jcm14145154.
5
Fibroblasts activated by miRs-185-5p, miR-652-5p, and miR-1246 shape the tumor microenvironment in triple-negative breast cancer via PATZ1 downregulation.由miR-185-5p、miR-652-5p和miR-1246激活的成纤维细胞通过下调PATZ1塑造三阴性乳腺癌的肿瘤微环境。
Cell Mol Life Sci. 2025 Jul 25;82(1):287. doi: 10.1007/s00018-025-05781-y.
6
Diagnostic and Therapeutic Potential of Selected microRNAs in Colorectal Cancer: A Literature Review.特定微小RNA在结直肠癌中的诊断和治疗潜力:文献综述
Cancers (Basel). 2025 Jun 25;17(13):2135. doi: 10.3390/cancers17132135.
7
Involvement of miRNAs in the Cluster of Metabolic Factors of MetS: Nutrition-Genome-MetS Axis.微小RNA在代谢综合征代谢因子簇中的作用:营养-基因组-代谢综合征轴
J Clin Med. 2025 Jun 14;14(12):4234. doi: 10.3390/jcm14124234.
8
A thematic analysis of prognostic, diagnostic, and therapeutic of circulating miRNA biomarkers in bortezomib-resistant multiple myeloma.硼替佐米耐药多发性骨髓瘤中循环miRNA生物标志物的预后、诊断和治疗的主题分析
SAGE Open Med. 2025 Apr 26;13:20503121251328486. doi: 10.1177/20503121251328486. eCollection 2025.
9
Stability of microRNAs in Canine Serum-A Prerequisite for Use as Biomarkers in Tumour Diagnostics.犬血清中微小RNA的稳定性——肿瘤诊断中用作生物标志物的先决条件
Vet Sci. 2025 Apr 21;12(4):390. doi: 10.3390/vetsci12040390.
10
Neurodegenerative disease-associated microRNAs acting as signaling molecules modulate CNS neuron structure and viability.作为信号分子的神经退行性疾病相关微小RNA调节中枢神经系统神经元的结构和活力。
Cell Commun Signal. 2025 Apr 24;23(1):196. doi: 10.1186/s12964-025-02199-8.
血浆循环 miR-99a-5p 表达:乳腺癌早期诊断的潜在生物标志物。
Int J Mol Sci. 2020 Oct 8;21(19):7427. doi: 10.3390/ijms21197427.
4
Pathway Analysis of Selected Circulating miRNAs in Plasma of Breast Cancer Patients: A Preliminary Study.血浆中选定循环 miRNA 的通路分析:一项初步研究。
Int J Mol Sci. 2020 Oct 2;21(19):7288. doi: 10.3390/ijms21197288.
5
miR‑28‑5p inhibits the migration of breast cancer by regulating WSB2.miR-28-5p 通过调控 WSB2 抑制乳腺癌的迁移。
Int J Mol Med. 2020 Oct;46(4):1562-1570. doi: 10.3892/ijmm.2020.4685. Epub 2020 Jul 27.
6
Impact of long-term storage and freeze-thawing on eight circulating microRNAs in plasma samples.长期储存和反复冻融对血浆样本中 8 种循环 microRNAs 的影响。
PLoS One. 2020 Jan 14;15(1):e0227648. doi: 10.1371/journal.pone.0227648. eCollection 2020.
7
Integrated copy number and miRNA expression analysis in triple negative breast cancer of Latin American patients.拉丁美洲患者三阴性乳腺癌的综合拷贝数与miRNA表达分析
Oncotarget. 2019 Oct 22;10(58):6184-6203. doi: 10.18632/oncotarget.27250.
8
Circulating miRNAs in Untreated Breast Cancer: An Exploratory Multimodality Morpho-Functional Study.未经治疗的乳腺癌中的循环微小RNA:一项探索性多模态形态功能研究。
Cancers (Basel). 2019 Jun 22;11(6):876. doi: 10.3390/cancers11060876.
9
Plasma MicroRNA Pair Panels as Novel Biomarkers for Detection of Early Stage Breast Cancer.血浆微小RNA对面板作为早期乳腺癌检测的新型生物标志物
Front Physiol. 2019 Jan 8;9:1879. doi: 10.3389/fphys.2018.01879. eCollection 2018.
10
MORC4 is a novel breast cancer oncogene regulated by miR-193b-3p.MORC4 是一种受 miR-193b-3p 调控的新型乳腺癌致癌基因。
J Cell Biochem. 2019 Mar;120(3):4634-4643. doi: 10.1002/jcb.27751. Epub 2018 Oct 15.